LEADER 03054nam 22005175 450 001 9910337523203321 005 20230831140748.0 010 $a3-030-16391-1 024 7 $a10.1007/978-3-030-16391-4 035 $a(CKB)4100000008424458 035 $a(DE-He213)978-3-030-16391-4 035 $a(MiAaPQ)EBC5795893 035 $a(PPN)248601903 035 $a(EXLCZ)994100000008424458 100 $a20190617d2019 u| 0 101 0 $aeng 135 $aurnn#008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aPrecision Medicine in Cancer Therapy /$fedited by Daniel D. Von Hoff, Haiyong Han 205 $a1st ed. 2019. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2019. 215 $a1 online resource (ix, 283 p.) 225 1 $aCancer Treatment and Research,$x2509-8497 ;$v178 311 $a3-030-16390-3 327 $aPart I: Individual types of cancer precision medicine, Hematological malignancies -- Lung cancer -- Breast cancer -- Rare malignancies -- Part II: Currently available techniques, Immunohistochemistry enabled precision medicine -- Genomics enabled precision medicine -- Proteomics enabled precision medicine -- Metabolomics enabled precision medicine, Part III: Future precision medicine -- Imaging precision medicine -- Single cell sequencing in precision medicine -- Microbiome in precision medicine -- Perspectives on precision medicine. 330 $aThis book presents the latest advances in precision medicine in some of the most common cancer types, including hematological, lung and breast malignancies. It also discusses emerging technologies that are making a significant impact on precision medicine in cancer therapy. In addition to describing specific approaches that have already entered clinical practice, the book explores new concepts and tools that are being developed. Precision medicine aims to deliver personalized healthcare tailored to a patient?s genetics, lifestyle and environment, and cancer therapy is one of the areas in which it has flourished in recent years. Documenting the latest advances, this book is of interest to physicians and clinical fellows in the front line of the war on cancer, as well as to basic scientists working in the fields of cancer biology, drug development, biomarker discovery, and biomedical engineering. The contributing authors include translational physicians with first-hand experience in precision patient care. 410 0$aCancer Treatment and Research,$x2509-8497 ;$v178 606 $aOncology 606 $aCancer 606 $aOncology 606 $aCancer Biology 615 0$aOncology. 615 0$aCancer. 615 14$aOncology. 615 24$aCancer Biology. 676 $a616.994 676 $a616.994 686 $a28.24.12.16$2EP-CLASS 702 $aVon Hoff$b Daniel D 702 $aHan$b Haiyong 906 $aBOOK 912 $a9910337523203321 996 $aPrecision Medicine in Cancer Therapy$91738131 997 $aUNINA